Basal cell carcinoma of the nasolabial fold: An apparently 'benign' tumour that often needs complex surgery

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 8, 2006, Pages 926-930

  Garcia, L ^b   Nagore, E ^a   Llombart, B ^a   Sanmartin, O ^a   Botella Estrada, R ^a   Requena, C ^a   Jorda, E ^b   Guillen, C ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Basal cell carcinoma; Mohs; Nasolabial fold; Surgery

Indexed keywords

IMIQUIMOD;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CHEEK; CLINICAL FEATURE; CONTROLLED STUDY; CREAM; FEMALE; FOLLOW UP; FOREHEAD; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYMPTOM; TUMOR VOLUME;

AGED; CARCINOMA, BASAL CELL; FACIAL NEOPLASMS; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES;

EID: 33747371613     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01673.x     Document Type: Article

References (16)

1. Randle HW. Basal cell carcinoma. Identification and treatment of the high-risk patient. Dermatol Surg 1996; 22: 255-261.
2. Batra RS, Kelley LC. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 2002; 138: 1043-1051.
3. Bialy TL, Whalen J, Veledar E et al. Mohs micrographic surgery vs traditional surgical excision: A cost comparison analysis. Arch Dermatol 2004; 140: 736-742.
4. Panje WR, Ceilley RI. The influence of embryology of the mid-face on the spread of epithelial malignancies. Laryngoscope 1979; 89: 1914-1920.
5. Mora RG, Robins P. Basal-cell carcinomas in the center of the face: special diagnostic, prognostic, and therapeutic considerations. J Dermatol Surg Oncol 1978; 4: 315-321.
6. Salasche SJ. Curettage and electrodesiccation in the treatment of midfacial basal cell epithelioma. J Am Acad Dermatol 1983; 8: 496-503.
7. Wentzell JM, Robinson JK. Embryologic fusion planes and the spread of cutaneous carcinoma. a review and reassessment. J Dermatol Surg Oncol 1990; 16: 1000-1006.
8. Nagore E, Llombart B, Compañ A et al. Mohs micrographic surgery of the medial canthus of the eye. A case-control study. Actas Dermosifiliogr 2002; 93: 406-412.
9. Lober CW, Fenske NA. Basal cell, squamous cell, and sebaceous gland carcinomas of the periorbital region. J Am Acad Dermatol 1991; 25: 685-690.
10. Fosko SW, Gibney MD, Holds JB. Basal cell carcinoma involving the lacrimal canaliculus. A documented mechanism of tumor spread. Dermatol Surg 1997; 23: 203-206.
11. Seccia A, Salgarello M, Bracaglia R et al. Malignant tumors of the orbital region. Analysis of cases examined from 1986 to 1995. Dermatol Surg 1997; 23: 565-570.
12. Hatano Y, Terashi H, Kurata S et al. Invasion of the lacrimal system by basal cell carcinoma. Dermatol Surg 1999; 25: 823-826.
13. Levine HL, Bailin PL. Basal cell carcinoma of the head and neck: identification of the high risk patient. Laryngoscope 1980; 90: 955-961.
14. Drake LA, Dinehart SM, Goltz RW et al. Guidelines of care for Mohs micrographic surgery. American Academy of Dermatology. J Am Acad Dermatol 1995; 33: 271-278.
15. Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15: 424-431.
16. Torres A, Niemeyer A, Berkes B et al. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma. Dermatol Surg 2004; 30: 1462-1469.